Antibodies elicited by influenza virus hemagglutinin fail to bind to synthetic peptides representing putative antigenic sites
- PMID: 2579329
- DOI: 10.1016/s0161-5890(85)80008-0
Antibodies elicited by influenza virus hemagglutinin fail to bind to synthetic peptides representing putative antigenic sites
Abstract
A number of peptides of the hemagglutinin (HA) of X-31 influenza virus have been synthesised. The amino acid sequences of some of these peptides represent regions of HA which have been postulated [Wiley et al., Nature, Lond. 289, 373-378 (1981)] to form the antigenic sites of this molecule. Animals were immunized with free peptide or peptide conjugated to a carrier and the resulting antisera examined for their capacities to bind to homologous peptide, whole HA, reduced and alkylated HA, and intact virus. Not all peptides examined in this way were immunogenic. Only antibodies raised against the C-terminus of HA1 peptide displayed binding to virus. This antiserum bound to the intact HA but not to the reduced and alkylated form of the molecule. These results raise questions as to the feasibility of using synthetic peptides of the influenza HA in short linear sequences to elicit neutralising antibody.
Similar articles
-
Immunogenic structure of the influenza virus hemagglutinin.Cell. 1982 Mar;28(3):477-87. doi: 10.1016/0092-8674(82)90202-1. Cell. 1982. PMID: 6176330
-
A novel approach for localization of the continuous protein antigenic sites by comprehensive synthetic surface scanning: antibody and T-cell activity to several influenza hemagglutinin synthetic sites.Immunol Commun. 1984;13(6):539-51. doi: 10.3109/08820138409061305. Immunol Commun. 1984. PMID: 6085322
-
I-Ad restricted T cell recognition of influenza hemagglutinin. Synthetic peptides identify multiple epitopes corresponding to antibody-binding regions of the HA1 subunit.J Immunol. 1989 Oct 15;143(8):2663-9. J Immunol. 1989. PMID: 2477451
-
Engineered immunoglobulin molecules as vehicles for T cell epitopes.Int Rev Immunol. 1993;10(2-3):265-78. doi: 10.3109/08830189309061701. Int Rev Immunol. 1993. PMID: 7689626 Review.
-
The development of chemically synthesized vaccines.Adv Vet Sci Comp Med. 1989;33:173-93. doi: 10.1016/b978-0-12-039233-9.50009-3. Adv Vet Sci Comp Med. 1989. PMID: 2467537 Review. No abstract available.
Cited by
-
Masking terminal neo-epitopes of linear peptides through glycosylation favours immune responses towards core epitopes producing parental protein bound antibodies.Sci Rep. 2020 Oct 28;10(1):18497. doi: 10.1038/s41598-020-75754-7. Sci Rep. 2020. PMID: 33116268 Free PMC article.
-
Development of a Genetically-Engineered, Candidate Polio Vaccine Employing the Self-Assembling Properties of the Tobacco Mosaic Virus Coat Protein.Biotechnology (N Y). 1986;4(7):637-641. doi: 10.1038/nbt0786-637. Biotechnology (N Y). 1986. PMID: 32226216 Free PMC article.
-
Antigenic characterization of recombinant hemagglutinin proteins derived from different avian influenza virus subtypes.PLoS One. 2010 Feb 5;5(2):e9097. doi: 10.1371/journal.pone.0009097. PLoS One. 2010. PMID: 20140098 Free PMC article.
-
A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains.J Virol. 1993 May;67(5):2552-8. doi: 10.1128/JVI.67.5.2552-2558.1993. J Virol. 1993. PMID: 7682624 Free PMC article.
-
Peptides as antigens. Importance of orientation.J Exp Med. 1986 Oct 1;164(4):1344-9. doi: 10.1084/jem.164.4.1344. J Exp Med. 1986. PMID: 3760779 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials